Georgia’s research secondment

Georgia Moffatt, now a Quality Improvement Advisor at South London and Maudsley NHS Foundation Trust, tells us about her research secondment and how it affected her skills and clinical work.

By NIHR Maudsley BRC at 30 Mar 2020
Read more >

Heroin injection associated with respiratory disorder

A single case study of an individual with longstanding heroin addiction has shown heroin-induced slow and ineffective breathing, as well as apnoea, in research from the NIHR Maudsley BRC.

By NIHR Maudsley BRC at 26 Mar 2020
Read more >

Thirty risk factors found during and after pregnancy for children developing psychosis

More than 30 significant risk factors have been identified for the development of psychotic disorders in offspring in research led by the NIHR Maudsley BRC. It is the first comprehensive meta-analysis of pre- and perinatal risk factors for psychosis in nearly 20 years.

By NIHR Maudsley BRC at 24 Mar 2020
Read more >

10,000 people could benefit from new migraine drug

Fremanezumab, a new drug preventing chronic migraine, has been recommended in final draft guidance from National Institute for health and Care Excellence (NICE) today (12 March 2020) following clinical trials based on research led by King’s College London.

By NIHR Maudsley BRC at 12 Mar 2020
Read more >

Study finds that Community Treatment Orders do not reduce hospital readmission rates or stays

In the first large, observational study with a control group in England and Wales, research funded by the NIHR Maudsley Biomedical Research Centre has found that Community Treatment Orders (CTOs) are associated with an increased risk of readmission as well as increased time spent in psychiatric hospitals, contrary to results from previous uncontrolled studies. Researchers suggest that these findings should be considered in future reforms to the UK Mental Health Act.

By NIHR Maudsley BRC at 5 Mar 2020
Read more >